Certification by the Swiss Biobanking Platform – VITA-Label
Building up a proper Governance through accountable mechanisms is key to foster trustworthiness and the pre-requisite for the appropriate use of biological resources. Our CK-CARE Biobank has recently been awarded by Swiss Biobanking Platform (SBP) with the VITA Label, which demonstrates compliance with the applicable legal and ethical framework. This labelling approach is part of […]
CK-CARE Team Meeting October 10th- 11th, 2022
This year’s CK-CARE team event in Davos focused on strengthening cross-center communication and collaboration.
Certification by the Swiss Biobanking Platform – OPTIMA-Label
Davos BioSciences AG achieved the official OPTIMA label of the Swiss Biobanking Platform for its biobank infrastructure as of 30.05.2022. This is another important step for Davos BioSciences AG and CK-CARE. The label attests to the full implementation of a QM system. The OPTIMA-Label confirms: “Compliance with the Good Biobanking Practices; in particular OECD Best […]
Certification by the Swiss Biobanking Platform
After some effort, Davos BioSciences AG achieved the official NORMA label of the Swiss Biobanking Platform for its biobank infrastructure as of 17.08.2021. This is an important step for Davos BioSciences AG and CK-CARE. The NORMA-Label confirms: “Compliance with professional standards is essential to perform our daily biobanking activities according to Good Biobanking Practices; in […]
Claudio Rhyner, PhD appointed as the new Managing Director
On 1 October 2020, Claudio Rhyner succeeded Dr. Georg Schäppi as Managing Director of CK-CARE. Georg Schäppi was appointed CEO at the University Children’s Hospital Zurich as of 1 December, 2020. Claudio Rhyner was born and grew up in Davos. After studying chemistry and molecular biology, he graduated specialising in asthma and allergy research. He […]
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Our founder, Prof. Thomas Bieber, published an important contribution in the treatment of AD: Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies. However, recent advances in understanding of […]
Kühne-Foundation Annual Report 2020
“Key priority of the Kühne Foundation is the support for training, further education as well as research and science in the area of logistics. This also includes Humanitarian Logistics and a project concentrating on free global trade. Another focal point is our medicine funding through research, therapy, and education in the fields of allergology and […]
Covid-19 risk increases with airborne pollen
When airborne pollen levels are higher, increased SARS-CoV-2 infection rates can be observed. These results were determined by a large-scale study conducted by an international team headed by researchers at the Technical University of Munich (TUM) and the Helmholtz Zentrum München. Members of high-risk groups could protect themselves by watching pollen forecasts and wearing dust […]
Continuing Medical Education Activities for Improved Management of Allergy
Effectiveness and sustainability of continuing medical education activities are, in general, a huge challenge. Given the frequency of allergic diseases, the increasing prevalence, the burden of the disease, the degree of suffering and the age of onset, there is a need for paediatricians to have in-depth knowledge and skills in allergology. We developed a needs-based […]
Exposure to farm animals protects farm children from asthma
(Natural News) Asthma is a common disease among most children, with the exception being farm children. Immunologists from the University of Zurich have pinpointed the cause: exposure to farm animals. Specifically, the researchers have identified a sialic acid in farm animals that has proven to be effective against lung tissue inflammation. The sialic acid is […]
